Botox 200 unit vials
Ended Awarded Last action
- Contract number
- SPE2DR26FKFU6
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $23,766
Award facts
- Contract value 100% obligated
- $23,765.76 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $23,765.76 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of BOTOX 200 Unit Vials. This firm fixed-price delivery order, issued on December 9, 2025, with an ultimate completion date of December 31, 2025, was made without a set-aside designation, demonstrating the contractor's competitive capability in unrestricted federal procurement. The award is issued under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, designated as contract SPE2DR, which was established on November 13, 2025, with a $499.999 billion ceiling value extending through December 31, 2036.
As a critical supplier within the federal pharmaceutical supply chain, DMS Pharmaceutical Group serves the Department of Defense healthcare system with a comprehensive portfolio spanning branded and generic prescription medications, biologics, vaccines, and specialty pharmaceuticals. The PPV-G GEN V program, part of a broader $30.3 billion acquisition strategy, positions the contractor as a regional prime vendor capable of fulfilling diverse and specialized pharmaceutical requirements for military healthcare facilities worldwide. The company's established performance on numerous delivery orders across multiple therapeutic categories demonstrates its capability to support recurring medical supply needs of the Department of Defense healthcare operations globally.
Quick answers
Who was awarded contract SPE2DR26FKFU6?
SPE2DR26FKFU6 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on December 9, 2025.
How much is contract SPE2DR26FKFU6 worth?
The government has obligated $23,766 on SPE2DR26FKFU6.
Is contract SPE2DR26FKFU6 an order under another contract?
Yes. SPE2DR26FKFU6 is a delivery order under SPE2DR25D9362, an indefinite delivery contract.
Was contract SPE2DR26FKFU6 competed?
The extent of competition for SPE2DR26FKFU6 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award